A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function.
- DOI
- 10.1517/14656566.2012.730519
- Published
- 2012 Dec
- Container
- Expert opinion on pharmacotherapy
- Publisher
- Not recorded
- Open access
- no
Credibility signals
serious concern Score 25/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1517/14656566.2012.730519,
title = {A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function.},
author = {Derosa G and Carbone A and D'Angelo A and Querci F and Fogari E and Cicero AF and Maffioli P},
year = {2012},
journal = {Expert opinion on pharmacotherapy},
doi = {10.1517/14656566.2012.730519},
url = {https://doi.org/10.1517/14656566.2012.730519}
}RIS
TY - JOUR TI - A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function. AU - Derosa G AU - Carbone A AU - D'Angelo A AU - Querci F AU - Fogari E AU - Cicero AF AU - Maffioli P PY - 2012 JO - Expert opinion on pharmacotherapy DO - 10.1517/14656566.2012.730519 UR - https://doi.org/10.1517/14656566.2012.730519 ER -
APA
G, D., A, C., A, D., F, Q., E, F., AF, C., & P, M. (2012). A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function.. Expert opinion on pharmacotherapy. https://doi.org/10.1517/14656566.2012.730519
Source records
- pubmed · retrieved 2026-09-25T08:43:21.859Z
- europe-pmc · retrieved 2026-09-25T08:43:21.881Z